Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-018076
Filing Date
2025-06-24
Accepted
2025-06-24 16:23:33
Documents
2
Period of Report
2025-06-21

Document Format Files

Seq Description Document Type Size
1 form3-06242025_080630.html 3  
1 form3-06242025_080630.xml 3 1672
2 ex24-06242025_080630.htm EX-24 6886
  Complete submission text file 0001415889-25-018076.txt   10088
Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Braunstein Scott (Reporting) CIK: 0001643875 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38997 | Film No.: 251069531

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)